Steve Valiquette
Stock Analyst at Barclays
(1.51)
# 3,522
Out of 5,141 analysts
147
Total ratings
47.42%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $14.90 | -36.24% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $4.74 | +153.16% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $947.48 | -34.99% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.47 | +264.37% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $18.15 | +32.23% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $76.69 | +12.14% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $43.24 | +96.58% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $532.30 | -43.64% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $38.92 | -12.64% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $229.90 | -54.33% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $85.94 | -36.00% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $19.93 | -34.77% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $230.49 | -38.39% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $34.63 | -85.56% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $106.55 | -46.50% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $208.19 | -60.61% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.99 | +5.94% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $46.57 | -33.43% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $151.00 | +148.34% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $40.05 | -52.56% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $189.83 | +200.27% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $224.44 | -71.48% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $280.31 | +10.59% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $290.00 | +94.83% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.63 | +4,515.38% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $8.16 | +132.84% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.56 | +180.90% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $7.34 | +172.48% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $77.21 | +236.74% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $14.90
Upside: -36.24%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $4.74
Upside: +153.16%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $947.48
Upside: -34.99%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.47
Upside: +264.37%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $18.15
Upside: +32.23%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $76.69
Upside: +12.14%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $43.24
Upside: +96.58%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $532.30
Upside: -43.64%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.92
Upside: -12.64%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $229.90
Upside: -54.33%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $85.94
Upside: -36.00%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $19.93
Upside: -34.77%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $230.49
Upside: -38.39%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $34.63
Upside: -85.56%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $106.55
Upside: -46.50%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $208.19
Upside: -60.61%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $16.99
Upside: +5.94%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $46.57
Upside: -33.43%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $151.00
Upside: +148.34%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $40.05
Upside: -52.56%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $189.83
Upside: +200.27%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $224.44
Upside: -71.48%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $280.31
Upside: +10.59%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $290.00
Upside: +94.83%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.63
Upside: +4,515.38%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $8.16
Upside: +132.84%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.56
Upside: +180.90%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $7.34
Upside: +172.48%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $77.21
Upside: +236.74%